Ben A. C. Dijkmans
#129,621
Most Influential Person Now
Ben A. C. Dijkmans's AcademicInfluence.com Rankings
Ben A. C. Dijkmansmedical Degrees
Medical
#2130
World Rank
#2530
Historical Rank
Rheumatology
#18
World Rank
#19
Historical Rank
Ben A. C. Dijkmansphilosophy Degrees
Philosophy
#6249
World Rank
#9251
Historical Rank
Logic
#3431
World Rank
#4586
Historical Rank
Download Badge
Medical Philosophy
Ben A. C. Dijkmans's Degrees
- Doctorate Medicine University of Amsterdam
- PhD Rheumatology University of Amsterdam
Why Is Ben A. C. Dijkmans Influential?
(Suggest an Edit or Addition)Ben A. C. Dijkmans's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. (1991) (2214)
- Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. (2004) (1783)
- Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. (2005) (1537)
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis (2009) (1304)
- Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis (1997) (1138)
- 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis (2011) (959)
- Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). (2005) (807)
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal (2009) (780)
- Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. (2006) (779)
- ASAS/EULAR recommendations for the management of ankylosing spondylitis (2005) (719)
- Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up. (2011) (699)
- COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. (2002) (660)
- Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis (2007) (555)
- New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS) (2009) (510)
- Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis. (2006) (495)
- Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. (2008) (431)
- Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. (2004) (423)
- Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. (1995) (381)
- Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. (2001) (379)
- Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. (2004) (367)
- Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. (2009) (361)
- Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation (2008) (356)
- Incidence and sources of native and prosthetic joint infection: a community based prospective survey (1997) (342)
- Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis (2004) (309)
- Consensus on a core set of domains for psoriatic arthritis. (2007) (289)
- Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. (2003) (286)
- Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study (2009) (276)
- Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. (1997) (256)
- Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study (2006) (255)
- Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. (2005) (248)
- Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative (2011) (234)
- Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study (2009) (232)
- Predictive factors of work disability in rheumatoid arthritis: a systematic literature review (2004) (230)
- Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. (2006) (224)
- Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis (2004) (218)
- A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study (2010) (217)
- Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis (2006) (212)
- Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative (2008) (210)
- Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis (2008) (210)
- Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. (1998) (206)
- Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. (2002) (203)
- Comparison of Treatment Strategies in Early Rheumatoid Arthritis (2007) (200)
- Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment (2006) (198)
- Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase (2010) (195)
- The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept (2010) (194)
- Predictors of radiographic joint damage in patients with early rheumatoid arthritis (2001) (190)
- Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial (2008) (185)
- Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. (2011) (184)
- Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. (2004) (184)
- The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study (2011) (182)
- Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. (1990) (182)
- Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial (2000) (178)
- Predicting the outcome of ankylosing spondylitis therapy (2011) (177)
- A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis (2004) (174)
- The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia (2010) (167)
- Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study (2010) (166)
- Conventional treatments for ankylosing spondylitis (2002) (164)
- Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation (2007) (162)
- The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients (2012) (159)
- Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy (2009) (157)
- The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium (2007) (157)
- A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. (1995) (153)
- Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity (2000) (152)
- Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis. (2002) (150)
- Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. (1998) (145)
- Comparison of high and low intensity training in well controlled rheumatoid arthritis. Results of a randomised clinical trial. (1996) (145)
- Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients (2011) (144)
- Is group physical therapy superior to individualized therapy in ankylosing spondylitis? A randomized controlled trial. (1993) (144)
- Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis. (2005) (140)
- Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis (2008) (139)
- Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment (2010) (137)
- Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs—from bench to bedside (2007) (133)
- Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. (2009) (131)
- Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. (2011) (130)
- The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis. (2003) (126)
- High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review (2012) (125)
- Long term high intensity exercise and damage of small joints in rheumatoid arthritis (2004) (125)
- Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial (2009) (124)
- Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study (2011) (122)
- Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study. (2012) (120)
- Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. (2002) (119)
- Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. (2008) (118)
- Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor α blockade (2008) (117)
- Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity. (2004) (117)
- Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis (2009) (117)
- Pregnancy and the risk of developing rheumatoid arthritis. (1990) (116)
- Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. (2009) (116)
- Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis (2010) (116)
- Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. (2003) (115)
- Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis (2010) (113)
- Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study. (1986) (112)
- Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. (2006) (112)
- Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension (2008) (108)
- Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies. (1987) (107)
- Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis (2007) (105)
- Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography. (2008) (105)
- Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis (2011) (103)
- Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. (2008) (103)
- A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue (2008) (102)
- Inactivating PSMB5 Mutations and P-Glycoprotein (Multidrug Resistance-Associated Protein/ATP-Binding Cassette B1) Mediate Resistance to Proteasome Inhibitors: Ex Vivo Efficacy of (Immuno)Proteasome Inhibitors in Mononuclear Blood Cells from Patients with Rheumatoid Arthritis (2012) (102)
- Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis. (2009) (102)
- Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial. (2004) (102)
- Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation (2009) (102)
- Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score (2007) (101)
- A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks (2013) (100)
- Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis (2007) (98)
- Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis (2006) (97)
- Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study (2004) (96)
- Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. (2006) (96)
- Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis. (2010) (95)
- Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino et al. (2006) (93)
- Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis (2005) (92)
- Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. (1994) (92)
- Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. (2003) (92)
- 18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study (2011) (91)
- The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis. (2011) (91)
- Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study (2008) (88)
- Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis (2010) (88)
- Predictors of functional status in patients with early rheumatoid arthritis (2000) (87)
- Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50–70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study (2004) (87)
- Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission. (2002) (86)
- Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment (2007) (86)
- Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method. (2003) (86)
- Reproducibility of bone mineral density measurement in daily practice (2004) (85)
- Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis. (2008) (85)
- Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis. (2005) (84)
- HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab (2012) (80)
- Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study (2010) (79)
- Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms. (2009) (78)
- No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis. (1998) (77)
- Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment. (1995) (77)
- Loss of Multidrug Resistance Protein 1 Expression and Folate Efflux Activity Results in a Highly Concentrative Folate Transport in Human Leukemia Cells* (2003) (76)
- Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial (2010) (76)
- Greater trochanteric pain syndrome (trochanteric bursitis) in low back pain. (1991) (76)
- Antibiotic prophylaxis in craniotomy: a prospective double-blind placebo-controlled study. (1988) (75)
- Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus. (2008) (75)
- High frequency of vertebral fractures in early spondylarthropathies (2012) (73)
- Efficacy, Tolerability and Cost Effectiveness of Disease-Modifying Antirheumatic Drugs and Biologic Agents in Rheumatoid Arthritis (2012) (73)
- Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis (2007) (71)
- One year outcome of undifferentiated polyarthritis (2002) (71)
- Recent advances in the management of rheumatoid arthritis (2010) (71)
- Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis. (2004) (71)
- High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis (2011) (71)
- Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial) (2007) (70)
- Human parvovirus B19 DNA in synovial fluid. (1988) (69)
- A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. (1994) (69)
- Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide. (2009) (69)
- Work ability of Dutch employees with rheumatoid arthritis (2005) (69)
- Eradication of Helicobacter pylori Does Not Reduce the Incidence of Gastroduodenal Ulcers in Patients on Long‐term NSAID Treatment: Double‐Blind, Randomized, Placebo‐Controlled Trial (2007) (68)
- Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus (2013) (68)
- Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial (2006) (64)
- Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis (2009) (64)
- Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study. (2007) (63)
- Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis. (2008) (63)
- Long-term follow-up of a high-intensity exercise program in patients with rheumatoid arthritis (2009) (62)
- CARD15 gene mutations are not associated with ankylosing spondylitis (2003) (61)
- Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies (2010) (61)
- Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products. (2006) (61)
- Subclinical renal dysfunction in rheumatoid arthritis. (1990) (60)
- Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis (2000) (60)
- Magnetic resonance imaging of the shoulder in patients with rheumatoid arthritis. (1990) (60)
- Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation (2006) (60)
- A clinical epidemiological study in low back pain. Description of two clinical syndromes. (1990) (59)
- Should we look for osteoporosis in patients with rheumatoid arthritis? (1998) (58)
- Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis (2011) (58)
- Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study (2012) (57)
- Infections after craniotomy: a retrospective study. (1986) (56)
- Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction. (2012) (56)
- Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study (2010) (56)
- No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis (2005) (56)
- Non-gonococcal infectious arthritis: a retrospective study. (1987) (56)
- Tumour necrosis factor α blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study (2009) (55)
- Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab. (2003) (55)
- Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study. (1991) (54)
- Cyclosporine in rheumatoid arthritis. (1992) (53)
- Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis. (2010) (53)
- Antioxidant intervention in rheumatoid arthritis: results of an open pilot study (2008) (53)
- Frequency of infection among patients with rheumatoid arthritis versus patients with osteoarthritis or soft tissue rheumatism. (1988) (52)
- Continuation of group physical therapy is necessary in ankylosing spondylitis: results of a randomized controlled trial. (1994) (52)
- Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score. (2005) (52)
- Oral calcitriol as a new therapeutic modality for generalized morphea. (1994) (52)
- Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis. (2008) (51)
- High prevalence of unemployment in patients with systemic lupus erythematosus: association with organ damage and health-related quality of life. (2008) (49)
- Discordance between objective and subjective assessment of functional ability of patients with rheumatoid arthritis. (1995) (49)
- The BeSt story: on strategy trials in rheumatoid arthritis (2009) (49)
- Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine. (1998) (49)
- Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab (2010) (49)
- Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A. An update from the International Kidney Biopsy Registry. (1996) (49)
- Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems (2009) (48)
- Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoids. (2006) (47)
- The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients. (2009) (47)
- Expression of a pathogen-response program in peripheral blood cells defines a subgroup of Rheumatoid Arthritis patients (2008) (46)
- Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complications (2012) (46)
- Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus (2005) (46)
- Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus (2006) (46)
- Lack of effect of TNFα blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies (2009) (46)
- Fumaric acid therapy for psoriatic arthritis. A randomized, double-blind, placebo-controlled study. (1992) (45)
- Stable bone mineral density in lumbar spine and hip in contrast to bone loss in the hands during long-term treatment with infliximab in patients with rheumatoid arthritis (2010) (45)
- Androgens and Ankylosing Spondylitis: A Role in the Pathogenesis? (1999) (45)
- Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis? (2007) (45)
- Assessment of shoulder function in rheumatoid arthritis. (1996) (45)
- Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs. (2002) (44)
- Reversible nephrotoxicity of cyclosporine in rheumatoid arthritis. (1990) (43)
- Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6‐month course of TNF inhibitors: prospective intervention study and partial economic evaluation (2009) (43)
- Folate supplementation and methotrexate. (1995) (43)
- Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial (2011) (42)
- Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuation (1997) (42)
- Bone metabolism is altered in preclinical rheumatoid arthritis (2010) (42)
- Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies. (2012) (42)
- Improvement of Thyroid Function in Hypothyroid Patients with Rheumatoid Arthritis After 6 Months of Adalimumab Treatment: A Pilot Study (2011) (41)
- Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNFα blockade: results from a prospective cohort study (2010) (41)
- Heart conduction disturbance: an HLA-B27 associated disease. (1991) (41)
- Longterm cyclosporine therapy in rheumatoid arthritis. (1991) (41)
- High levels of human anti-human antibodies to adalimumab in a patient not responding to adalimumab treatment (2006) (41)
- The onset of rheumatoid arthritis in relation to pregnancy and childbirth. (1993) (40)
- IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis. (2008) (40)
- The cervical spine in rheumatoid arthritis: relationship between neurologic signs and morphology on MR imaging and radiographs (1996) (40)
- Serum testosterone levels are not elevated in patients with ankylosing spondylitis. (1998) (39)
- Gonadal and adrenal sex steroids in ankylosing spondylitis. (2000) (39)
- The limited value of the Health Assessment Questionnaire as an outcome measure in short term exercise trials. (1997) (39)
- Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use. (1990) (39)
- Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritis (2010) (38)
- The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study (2008) (38)
- Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study (2011) (37)
- Statin therapy might be beneficial for patients with ankylosing spondylitis (2005) (37)
- The proteasome inhibitor bortezomib inhibits the release of NF kappa B-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients (2009) (36)
- pANCA, ASCA, and OmpC Antibodies in Patients with Ankylosing Spondylitis without Inflammatory Bowel Disease (2010) (36)
- Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis. (2007) (35)
- Sleep apnoea caused by rheumatoid arthritis. (1998) (35)
- Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis (2009) (34)
- Folate Receptor as a Potential Delivery Route for Novel Folate Antagonists to Macrophages in the Synovial Tissue of Rheumatoid Arthritis Patients (2008) (34)
- Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis (2012) (33)
- Cyclosporine and chloroquine synergistically inhibit the interferon-gamma production by CD4 positive and CD8 positive synovial T cell clones derived from a patient with rheumatoid arthritis. (1992) (33)
- Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project (2017) (32)
- Reproducibility of performance measures of physical function based on the BASFI, in ankylosing spondylitis. (2009) (32)
- A systematic comparison of rheumatoid arthritis and ankylosing spondylitis. (2009) (32)
- Innovative treatment strategies for patients with rheumatoid arthritis (2008) (32)
- Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis. (2000) (32)
- Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis (2010) (32)
- Bone mineral density in patients with rheumatoid arthritis treated with infliximab (2005) (31)
- Cardiovascular Risk Profile of Antirheumatic Agents in Patients with Osteoarthritis and Rheumatoid Arthritis (2012) (31)
- Treatment of spondyloarthropathy with 5-aminosalicylic acid (mesalazine): an open trial. (2000) (31)
- Oral contraceptive treatment for rheumatoid arthritis: an open study in 10 female patients. (1989) (30)
- Dyslipidaemia, statins and rheumatoid arthritis (2009) (30)
- Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. (1992) (29)
- Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study. (2008) (29)
- The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis (1996) (29)
- Drug-free remission: is it already possible? (2011) (29)
- Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial. (2001) (29)
- Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis (2008) (28)
- Biologics in early rheumatoid arthritis. (2005) (27)
- Effects of high dose IV pamidronate on disease activity and bone metabolism in patients with active RA: a randomized, double-blind, placebo-controlled trial. (2003) (27)
- Outcome of cervical spine surgery in patients with rheumatoid arthritis (2001) (27)
- Infectious arthritis caused by Propionibacterium acnes: a report of two cases. (1989) (27)
- Costs of treating bleeding and perforated peptic ulcers in The Netherlands. (2004) (27)
- The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels (2007) (27)
- Iliac crest pain syndrome in low back pain. A double blind, randomized study of local injection therapy. (1991) (26)
- A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study (2010) (26)
- Total knee arthroplasty infection due to Gemella haemolysans. (1992) (26)
- The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in seropositive arthralgia patients (2010) (26)
- Tranexamic acid, an inhibitor of plasminogen activation, reduces urinary collagen cross-link excretion in both experimental and rheumatoid arthritis. (1998) (25)
- Hematogenous candida vertebral osteomyelitis treated with ketoconazole (1982) (25)
- A gastroscopic study of the predictive value of risk factors for non-steroidal anti-inflammatory drug-associated ulcer disease in rheumatoid arthritis patients. (1994) (25)
- Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice (2005) (24)
- Flucloxacillin-associated liver damage. (1982) (24)
- Antimalarial drug induced decrease in creatinine clearance. (1995) (24)
- Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors (2013) (24)
- Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activity (2011) (23)
- Effects of dehydroepiandrosterone administration on disease activity in patients with rheumatoid arthritis. (1998) (23)
- Cyclosporine in common clinical practice: an estimation of the benefit/risk ratio in patients with rheumatoid arthritis. (1994) (23)
- Ferritin and serum transferrin receptor predict iron deficiency in anemic patients with rheumatoid arthritis. (2001) (23)
- Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis (2001) (22)
- Serological bone markers and joint damage in early polyarthritis. (2004) (22)
- Eosinophilic fasciitis after allogeneic bone marrow transplantation. (1990) (22)
- Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice (2011) (22)
- Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor β1 (TGFB1) gene polymorphisms (2005) (22)
- Combination Therapy for Rheumatoid Arthritis (2001) (21)
- The effect of intravenous pamidronate versus oral alendronate on bone mineral density in patients with osteoporosis (2005) (21)
- Inactivating PSMB 5 Mutations and P-Glycoprotein ( Multidrug Resistance-Associated Protein / ATP-Binding Cassette B 1 ) Mediate Resistance to Proteasome Inhibitors : Ex Vivo Efficacy of ( Immuno ) Proteasome Inhibitors in Mononuclear Blood Cells from Patients with Rheumatoid Arthritis (2012) (21)
- Polymyalgia rheumatica and temporal arteritis: A retrospective study of 111 patients (1995) (21)
- Methotrexate treatment and mortality in rheumatoid arthritis (2002) (20)
- Rheumatoid arthritis: involvement of the synovium in the preclinical phase? (2011) (20)
- Are biologics more effective than classical disease-modifying antirheumatic drugs? (2008) (20)
- Increased risk of developing ankylosing spondylitis among first-born children. (2000) (20)
- The effect of co-trimoxazole on serum creatinine. (1981) (20)
- Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function loss. (1999) (20)
- Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy (2013) (20)
- Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study (2016) (20)
- The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine. (2010) (20)
- High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis (2009) (19)
- High disease activity is a predictor of cortical hand bone loss in post-menopausal patients with established rheumatoid arthritis: a 5-year multicentre longitudinal study. (2010) (19)
- Minocycline in the treatment of rheumatoid arthritis: relationship of serum concentrations to efficacy. (1995) (19)
- What do we miss? ASAS non-responders on anti-TNF therapy show improvement in performance-based physical function. (2013) (18)
- Rational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment. (1993) (18)
- Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use (1994) (18)
- Sulfasalazine sensitises human monocytic/macrophage cells for glucocorticoids by upregulation of glucocorticoid receptor α and glucocorticoid induced apoptosis (2007) (18)
- Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans. (1997) (18)
- Sjögren's syndrome: an unusual cause of Bell's palsy (2001) (18)
- Helicobacter pylori Eradication in Patients on Long-term Treatment With NSAIDs Reduces the Severity of Gastritis: A Randomized Controlled Trial (2009) (17)
- Early-onset polyarthritis as presenting feature of intestinal infection with Strongyloides stercoralis. (2003) (17)
- DR4 prevalence related to the age at disease onset in female patients with rheumatoid arthritis. (1989) (17)
- Tenosynovitis caused by Exophiala mansonii in an immunocompromised host. (1988) (17)
- Elevated liver enzymes in patients with ankylosing spondylitis treated with etanercept (2012) (17)
- Decrease of fructosamine levels during treatment with adalimumab in patients with both diabetes and rheumatoid arthritis. (2007) (17)
- Paraplegia in a patient receiving anti-tumor necrosis factor therapy for rheumatoid arthritis: comment on the article by Mohan et al. (2003) (17)
- Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis. (1995) (16)
- Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis (1999) (16)
- Effects of sulfasalazine treatment on serum immunoglobulin levels in children with juvenile chronic arthritis. (2001) (16)
- Sulfasalazine Down-Regulates the Expression of the Angiogenic Factors Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase and Interleukin-8 in Human Monocytic-Macrophage THP1 and U937 Cells (2004) (16)
- Dutch patients with familial and sporadic ankylosing spondylitis do not differ in disease phenotype. (2002) (16)
- Brain abscess due to streptobacillus moniliformis and actinobacterium meyerii (1984) (15)
- Serum creatinine levels two years later: follow-up of a placebo-controlled trial of cyclosporine in rheumatoid patients. (1988) (15)
- Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitis. (2003) (15)
- Does cyclosporin A cause cancer? (1999) (15)
- Rituximab and thyroid function. (2009) (15)
- Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. (2008) (15)
- No effect of misoprostol on renal function of rheumatoid patients treated with diclofenac. (1991) (15)
- Effect of cloxacillin prophylaxis on the bacterial flora of craniotomy wounds. (1990) (15)
- Imported Armillifer pentastomiasis: report of a symptomatic infection in The Netherlands and mini-review. (2014) (15)
- Antibiotics as disease modifiers in arthritis. (1993) (14)
- One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapy (2016) (14)
- Objective Evaluation of Physical Functioning after Tumor Necrosis Factor Inhibitory Therapy in Patients with Ankylosing Spondylitis: A Selection of 3 Feasible Performance-based Tests (2015) (14)
- Pulmonary Arterial Hypertension in Systemic Sclerosis Is Associated with Profound Impairment of Microvascular Endothelium-dependent Vasodilatation (2012) (14)
- Decreased level of antibodies against Helicobacter pylori in patients with rheumatoid arthritis receiving intramuscular gold. (1992) (14)
- Loss of imprinting of IGF2 characterises high IGF2 mRNA-expressing type of fibroblast-like synoviocytes in rheumatoid arthritis (2009) (13)
- Effect of bacterial competition on the opsonization, phagocytosis, and intracellular killing of microorganisms by granulocytes (1985) (13)
- Cervical spine involvement is rare in early arthritis (2005) (13)
- Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritis. (2004) (13)
- Muscle cramps in the calf as presenting symptom of sarcoidosis. (1991) (13)
- Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates (2009) (13)
- Comparison of the baseline disease activity of early oligo- and polyarthritis in sequential years. (2004) (12)
- Raised plasma renin and prorenin in rheumatoid vasculitis. (1990) (12)
- Duration of pre-rheumatoid arthritis anti-cyclic citrullinated peptide positivity is positively associated with age at seroconversion (2008) (12)
- Prevalence of Chlamydia trachomatis in urine of male patients with ankylosing spondylitis is not increased (2000) (12)
- Iliac crest pain syndrome in low back pain: frequency and features. (1991) (11)
- A comparison between the simplified erosion and narrowing score and the Sharp–van der Heijde score: post hoc analysis from the BeSt study (2010) (11)
- Multiple plaques of morphea developing in a patient with eosinophilic fasciitis. (1992) (11)
- IL10 GGC Haplotype Is Positively and HLA-DQA1*05-DQB1*02 Is Negatively Associated with Radiographic Progression in Undifferentiated Arthritis (2010) (11)
- Spondyloarthropathy and idiopathic inflammatory bowel diseases. (1997) (11)
- Low dose cyclosporine in early rheumatoid arthritis: effective and safe after two years of therapy when compared with chloroquine. (1996) (11)
- Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome (2009) (11)
- Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice. (1984) (11)
- Severe aortic regurgitation in RF positive polyarticular JIA (2002) (11)
- Laboratory screening for side effects of disease modifying antirheumatic drugs in daily rheumatological practice. (1998) (11)
- Upper gastrointestinal manifestations in rheumatoid arthritis patients: intrinsic or extrinsic pathogenesis? (1990) (11)
- Efficacy of cloxacillin prophylaxis in craniotomy: a one year follow-up study. (1991) (10)
- Platelet- derived growth factor receptor-beta and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study (2011) (10)
- SLEEP APNOEA CAUSED BY RHEUMATOID ARTHRITIS. AUTHORS' REPLY (1999) (10)
- Sesame oil in injectable gold: two drugs in one? (1997) (10)
- A double-blind study on the effect of discontinuation of gold therapy in patients with rheumatoid arthritis (2005) (10)
- Tenosynovitis due to Mycobacterium avium-intracellulare: case report and a review of the literature. (1992) (10)
- Reticular erythematous mucinosis syndrome in a patient with polyarthritis. (1986) (9)
- Osteoporosis in patients with rheumatoid arthritis: tip of the iceberg? (2000) (9)
- Destructive joint disease in α-mannosidosis. A case report and review of the literature (2004) (8)
- Androgenizing effects of low-dose cyclosporin in male patients with early RA. (1998) (8)
- Clinical approaches to early inflammatory arthritis (2009) (8)
- Alizarin red S staining of synovial fluid in inflammatory joint disorders. (1991) (8)
- Ankylosing spondylitis : diagnosis and management (2006) (8)
- Dehydroepiandrosterone Sulfate in Patients with Rheumatoid Arthritis (1999) (8)
- Outcome in adults with juvenile idiopathic arthritisComparison of the DUTCH‐AIMS2 between JIA and RA (2003) (8)
- Facilitating the Use of COBRA Combination Therapy in Early Rheumatoid Arthritis: A Pilot Implementation Study (2009) (8)
- Decreased Recurrence Rate of Anterior Uveitis in Ankylosing Spondylitis Treated with Adalimumab - An Interim Analysis (2010) (8)
- Methotrexate treatment and mortality in rheumatoid arthritis. Authors' reply (2002) (8)
- Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al. (2005) (8)
- NSAID-associated upper gastrointestinal damage in patients with rheumatoid arthritis. (1995) (8)
- CCP levels anti-cyclic citrullinated peptide antibodies The role of the shared epitope in arthralgia with (2008) (7)
- Risk of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty. Is prolonged thromboprophylaxis warranted or dangerous? (1999) (7)
- Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide (2018) (7)
- Prevention of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty: a continuing matter of debate (2001) (7)
- IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis (2009) (7)
- Combined activity of metronidazole and gentamicin on Bacteroides fragilis in vivo and in vitro. (1985) (7)
- No effect of intramuscular gold therapy on serological parameters of Helicobacter pylori infection in patients with rheumatoid arthritis: a 12 month prospective study. (1994) (7)
- A swinging heart as complication of systemic lupus erythematosus (2007) (7)
- Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs (2000) (7)
- Development of anti-drug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up (2013) (7)
- Atrioventricular conduction disturbance as an early feature of Reiter's syndrome. (1988) (7)
- Bacterial arthritis caused by mycobacterium terrae (1981) (7)
- The effect of Helicobacter pylori eradication on C-reactive protein and the lipid profile in patients with rheumatoid arthritis using chronic NSAIDs. (2009) (6)
- Oral contraceptives and the risk of rheumatoid arthritis: the great transatlantic divide? (1989) (6)
- Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al. (2008) (6)
- Platelet-derived growth factor receptor-b and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study (2011) (6)
- Oral contraceptives and rheumatoid arthritis; further evidence for a protective effect independent of duration of pill use. (1989) (6)
- OP0151 Cobra-light therapy is clinically non-inferior to original cobra therapy in the treatment of early rheumatoid arthritis (2013) (6)
- High incidence of vertebral and non-vertebral fractures in the ostra-cohort study: A 5 year follow-up study in postmenopausal women with rheumatoid arthritis (2010) (5)
- The frequency of extremely low serum pepsinogen, indicative of corpus gastritis with severe atrophy, in rheumatoid arthritis, other chronic rheumatic diseases and non-rheumatic diseases. (1993) (5)
- Effect of the Application of Trial Inclusion Criteria on the Efficacy of Adalimumab Therapy in a Rheumatoid Arthritis Cohort (2011) (5)
- Lyme borreliosis: a possible hidden cause of heart block of unknown origin in men with pacemakers. (1991) (5)
- Phenylbutazone can spuriously elevate unextracted testosterone assay results in patients with ankylosing spondylitis. (2000) (5)
- Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS) (2008) (5)
- Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis (2004) (5)
- Bisphosphonates for osteoporosis. (2011) (5)
- Methotrexate and its effect on the anti-GAD titre in two patients with rheumatoid arthritis and diabetes mellitus (2008) (5)
- Prolonged bleeding time during azlocillin therapy. (1980) (4)
- Melkersson-Rosenthal syndrome in a patient with sero-negative oligoarthritis. (1989) (4)
- Serum aluminium concentrations in patients with rheumatoid arthritis. (1987) (4)
- Rheumatoid arthritis as important independent risk factor for incident cardiovascular disease (2008) (4)
- Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice. (1985) (4)
- Do oral contraceptives prevent rheumatoid arthritis? (1986) (4)
- The pharmacokinetics of metronidazole and tinidazole in patients with mixed aerobic--anaerobic infections. (1982) (4)
- Is there any evidence for an association between ankylosing spondylitis and Borrelia burgdorferi infection? (1992) (4)
- Serum dehydroepiandrosterone sulphate levels in patients with early rheumatoid arthritis: positive association with C-reactive protein, but not with HLA-DR genotype. (1998) (4)
- Results of a questionnaire on the treatment of patients with Behçet's syndrome: a trend for more intensive treatment. (2012) (4)
- Extracapillary glomerulonephritis in a patient with juvenile chronic arthritis. (1996) (4)
- Folate receptor β: a novel target for therapeutic intervention in rheumatoid arthritis? (2009) (3)
- Elevation of serum aluminium concentrations in patients with rheumatoid arthritis treated with drugs containing aluminium. (1989) (3)
- Predictors of stenosing tenosynovitis in the hand and hand-related activity limitations in patients with rheumatoid arthritis. (2011) (3)
- Sarcoidosis post partum: a description of four cases. (1989) (3)
- Melkersson-Rosenthal syndrome and arthritis. (1990) (3)
- Destructive joint disease in alpha-mannosidosis. A case report and review of the literature. (2004) (3)
- Increased prevalence of spondylarthropathies in parents of children with pauciarticular juvenile chronic arthritis, type 1 (1993) (3)
- Human leucocyte antigen phenotypes and gold-induced remissions in patients with rheumatoid arthritis. (1995) (3)
- IFN/TNF cross-regulation in vivo during infliximab treatment in rheumatoid arthritis (2008) (3)
- [Correct use of methotrexate]. (2009) (3)
- Skin test responsiveness to Mycobacterium tuberculosis, HLA-DR4, and rheumatoid arthritis. (1989) (3)
- Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis. (2000) (3)
- The prevalence of H. pylori is still substantial in rheumatic patients (2002) (3)
- Minocycline in active rheumatoid arthritis. A placebo-controlled trial. (1994) (3)
- Serum values of pepsinogens and antibodies to Helicobacter pylori in relation to a history of peptic ulcer disease and NSAID use. (1995) (3)
- IDENTIFICATION OF ANTI-TNF CANDIDATES BASED ON PREDICTED RESPONSE AND REMISSION IN ANKYLOSING SPONDYLITIS (2010) (3)
- Echocardiography is not sufficient to diagnose pulmonary arterial hypertension in systemic sclerosis: comment on the article by Wigley et al. (2006) (3)
- Sensitization of Leukemic Cells for Glucocorticoids by Inhibition of NFκB Activity. (2004) (3)
- Preferential decrease in IgG 4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis (2009) (3)
- 537 INFLIXIMAB (IFX) MIGHT BE PROTECTIVE AGAINST PROGRESSIVE RADIOGRAPHIC INTERPHALANGEAL OSTEOARTHRITIS (OA) (2008) (3)
- Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: A randomized, double blind placebo controlled trial (2004) (3)
- Antimetabolites in the Treatment of Arthritis: Current Status of the Use of Antimetabolites (2004) (3)
- [Comparison of azathioprine and methotrexate in rheumatoid arthritis: an open-randomized clinical study]. (1994) (2)
- Penetration of cyclosporin into synovial fluid in rheumatoid arthritis (2004) (2)
- Juvenile ankylosing spondylitis in X-linked agammaglobulinaemia. (1993) (2)
- Predictability of serum concentrations of aminoglycosides after haemodialysis (2004) (2)
- Efficacy of rifamycin SV and vancomycin againstBacteroides fragilis in vitro and in experimentally infected mice (2005) (2)
- Expression profiling of ABC transporters in peripheral blood lymphocytes and monocyte-derived macrophages of rheumatoid arthritis patients (2020) (2)
- Magnetic resonance imaging is normal in the iliac crest pain syndrome. (1993) (2)
- [Clinical, bacteriological and cost-saving effects of antibiotic prophylaxis in craniotomy]. (1992) (2)
- A double-blind parallel group comparative study of lonazolac-calcium and diclofenac in patients with rheumatoid arthritis. (1988) (2)
- Concentration dependency of cyclosporin and chloroquine as inhibitors of cell proliferation and immunoglobulin production upon mitogen stimulation of mononuclear cells. (1990) (2)
- FRI0071 Does psychological status drive patient global assessment for rheumatoid arthritis patients who do not have any clinical signs of inflammation? an exploratory analysis of near-remission using the rheumatoid arthritis impact of disease (RAID) score. (2013) (2)
- Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID- treatment - A randomized, placebo controlled trial. (2004) (2)
- A welcome address for the new criteria (2010) (2)
- Synergistic and additive effects of disease modifying anti-rheumatic drugs combined with chloroquine on the mitogen-driven stimulation of mononuclear cells. (1990) (2)
- arthralgia: a randomised trial with levels and arthritis development in patients Effect of dexamethasone on autoantibody (2010) (2)
- Inactivating PSMB 5 mutations and P-glycoprotein ( MDR 1 / ABCB 1 ) mediate resistance to proteasome inhibitors : ex vivo efficacy of ( immuno ) proteasome inhibitors in mononuclear blood cells from rheumatoid arthritis patients (2013) (2)
- Effects of anti-rheumatic drugs on in vitro mitogenic stimulation of peripheral blood mononuclear cells. (1988) (2)
- Pharmacological induction of type I IFN activity following therapy with rituximab determines clinical response in rheumatoid arthritis (2011) (2)
- Effects of drugs onin vitro mitogenic stimulation of peripheral mononuclear cells (1988) (1)
- [Alendronate more effective than alfacalcidol in the prevention of osteoporosis in patients with rheumatic disease who are starting glucocorticoid therapy]. (2007) (1)
- [Methotrexate: safe if prescribed correctly]. (2009) (1)
- [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs]. (1999) (1)
- [Prevention of gastroduodenal disorders with the use of non-steroidal anti-inflammatory drugs]. (1991) (1)
- Targeting the immunoproteasome with the second generation proteasome inhibitor ONX 0914: effects on IFN-alpha-induced monocyte-derived dendritic cells (119.4) (2012) (1)
- Induction of IFN type I biology following therapy determines clinical response to rituximab in rheumatoid arthritis (2011) (1)
- Glucocorticoid-resistance in childhood leukaemia (2007) (1)
- Basic (PS01–PS58) (2012) (1)
- Alefacept selectively reduces memory-effector (CD45RO+) T cells and improves clinical outcomes in psoriasis and psoriatic arthritis (2002) (1)
- [Pharmacological prevention of osteoporosis in patients on corticosteroid medication]. (1998) (1)
- Is bone turnover adequately suppressed in osteoporotic patients treated with bisphosphonates (2009) (1)
- Disease modifying anti-rheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study (2006) (1)
- Antifolate drug combinations for inflammatory diseases (2007) (1)
- Questionnaire on NSAID Gastropathy among Dutch Rheumatologists (2000) (1)
- A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma (2007) (1)
- Changes in hand bone mineral density and the association with the level of disease activity in patients with RA (2011) (1)
- UPPER GASTROINTESTINAL COMPLAINTS AND COMPLICATIONS IN CHRONIC RHEUMATOID PATIENTS IN COMPARISON WITH OTHER CHRONIC DISEASES (VOL 31, PG 747, 1992) (1993) (1)
- Changing Phenotype of Diffuse Idiopathic Skeletal Hyperostosis Over Time: Comment on the Article by Saleem and Hawass (2015) (1)
- Loss of imprinting of IGF 2 characterises high IGF 2 mRNA-expressing type of fibroblast-like synoviocytes in rheumatoid arthritis (2010) (1)
- Third International Symposium for health professionals in rheumatology (1990) (1)
- Spondylarthropathies (including psoriatic arthritis) 244. Validity of Colour Doppler and Spectral Doppler Ultrasound of Sacroilicac Joints Againts Physical Examination as Gold Standard (2011) (1)
- Folates and antifolates in rheumatoid arthritis (2013) (1)
- ) gene mutation and overexpression of PSMB5 protein PSMB5 Molecular basis of bortezomib resistance: proteasome subunit ²5 ( (2009) (0)
- Development of antibodies against humanized antitumor necrosis factor and loss of efficacy in a black spider monkey with inflammatory bowel disease. (2009) (0)
- Emotional well-being in young adults with and without arthritis (1995) (0)
- UvA-DARE ( Digital Academic Repository ) Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis (2009) (0)
- SAT0158 Associates with and extent of reduced bone mineral density (bmd) in female rheumatoid arthritis (ra) patients: the oslo, truro, amsterdam (ostra) collaborative study (2001) (0)
- In vitro and in vivo efficacy of drugs against Bacteroides fragilis (0)
- IFN signature determines responder status on B cell depletion in rheumatoid arthritis patients (2010) (0)
- Main disease problems of young adults with artritis (1995) (0)
- opinion including uncertainty appraisal (part I): classification of paper patients by expert classification criteria for axial spondyloarthritis SpondyloArthritis international Society The development of Assessment of (2009) (0)
- Cloxacillin prophylaxis in craniotomies reduces costs of health care. (1991) (0)
- Abstracts of Dutch Ph.D. Theses (1985) (0)
- HUMAN LEUCOCYTE ANTIGEN PHENOTYPES AND GOLD-INDUCED REM ISSIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS (2019) (0)
- arthritis . degradation after intravenous bisphosphonate ( pamidronate ) in rheumatoid Short term whole body retention in relation to rate of bone resorption and cartilage (2004) (0)
- Adalimumab sustains improvement in spinal mobility in as patients through 104 weeks - Results from atlas (2008) (0)
- PsA Best Practices in 2006 (2006) (0)
- Destructive arthropathy after successful renal transplantation. (1990) (0)
- Systematic review of the cost e V ectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs (2000) (0)
- [Total atrioventricular block following a tick bite]. (2008) (0)
- Parameters contributing to inflammatory back pain (IBP) according to experts (2005) (0)
- Chapter 1.2 The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study (2010) (0)
- Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice. (1985) (0)
- CLINICAL RESPONSE AND PARTIAL REMISSION SUSTAINED THROUGH 3 YEARS OF ADALIMUMAB TREATMENT IN THE ATLAS TRIAL (2009) (0)
- Persistent neonatal hypoglycaemia caused by arterial positioning of the umbilical venous catheter (2008) (0)
- Effects of cyclosporin and chloroquine on the mitogen-driven cell proliferation and Ig production of human mononuclear cells (2005) (0)
- 4 The clinical relevance of immunogenicity in a long-term follow-up cohort of adalimumab treated rheumatoid arthritis patients (2011) (0)
- FRI0134 Increased progression of carotid intima media thickness in thyroid peroxidase antibody positive rheumatoid arthritis patients (2013) (0)
- The importance of control opportunities in the work for people with rheumatoid arthritis (2003) (0)
- Molecular basis of antifolate efficacy in the treatment of chronic inflammatory diseases (2009) (0)
- Glucocorticoid resistentie in kinderleukemie (2007) (0)
- where necessary, can lead to new levels of disease control in early RA. (2011) (0)
- Lack of effect of doxyxyxline on disease activity and pyridinoline excretion rates in rheumatoid arthritis : a double-blind placebo-controlled study (2000) (0)
- Proteasome inhibitors and effects on immune effector cells in autoimmunity and cancer (2013) (0)
- Muscle crampsinthecalf aspresenting symptomof sarcoidosis (1991) (0)
- Chapter 2 . 2 Pharmacogenomics in rituximab treated rheumatoid arthritis patients 2 . 2 B The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients (2013) (0)
- Chapter 1 . 4 Thyroid function upon biological treatment in rheumatoid arthritis 1 . 4 B Rituximab and Thyroid function (2013) (0)
- 34 : 343-346 HUMAN LEUCOCYTE ANTIGEN PHENOTYPES AND GOLD-INDUCED REM ISSIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS (2017) (0)
- Limitations on generalizibility of remarkble study on new strategy of treatment in patients with rheumatoid arthritis (2019) (0)
- Rheumatoid Arthritis Impact of Disease Questionnaire (2020) (0)
- Antagonism byd-penicillamine of the suppression of PWM-stimulated mononuclear cells by chloroquine (2005) (0)
- [Drugs in the treatment of rheumatoid arthritis]. (1987) (0)
- REM ISSIONS IN PATIENTS WITH RHEUM ATOID ARTHRITIS (1995) (0)
- Implementation of recommended non-pharmacotherapy in rheumatology practice: need for improvement. (2016) (0)
- [A strain of Trichomonas vaginalis with reduced sensitivity for metronidazole]. (1982) (0)
- SAT0159 Non-vertebral fractures and its associates in female rheumatoid arthritis (ra) patients: the oslo, truro, and amsterdam (ostra) collaborative study (2001) (0)
- [Treatment of the obstructive sleep-apnea syndrome in adults]. (2004) (0)
- Research toward the mechanisms of resistance against Disease Modifying Anti-rheumatic Drugs (DMARDs) in the treatment of rheumatoid arthritis patients (2006) (0)
- articleAccelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis (2015) (0)
- Cardiovascular disease and Rheumatoid Arthritis (2011) (0)
- [A fascinating disease?]. (1989) (0)
- Increased glucocorticoid sensitivity of leukemic cells by inhibiting NFκB activation (2005) (0)
- THU0158 Six year follow-up study of bone mineral density in patients with systemic lupus erythematosus (2013) (0)
- Towards personalized treatment: predictors of short term HAQ response in recent onset active RA are different from predictors of rapid radiological progression (2012) (0)
- SpondyloArthritis international Society (ASAS) exercise by experts from the Assessment of patients with chronic back pain: a real patient New criteria for inflammatory back pain in (2009) (0)
- anti-infliximab formation ankylosing spondylitis is correlated with Decreased clinical response to infliximab in (2007) (0)
- AB0558 Three easy tests of physical functioning (aspi) show improvement after anti-tnf therapy, even in asas20 non-responders in ankylosing spondylitis (2013) (0)
- Efficacy of serology driven “test and treat strategy” for eradication of H. pylori in patients with rheumatic disease in the Netherlands (2011) (0)
- 5 (PSMB5) gene mutation and overexpression of PSMB5 protein β Molecular basis of bortezomib/Velcade® resistance: proteasome subunit (2013) (0)
- Age of onset in successive generations of patients with a spondyloarthropathy. (1996) (0)
- University of Groningen Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus Bultink, (2015) (0)
- [Pharmacotherapy of patients with (early) rheumatoid arthritis]. (2000) (0)
- A prediction model for the development of rheumatoid arthritis in anti-CCP and/or IgM rheumatoid factor positive arthralgia patients (2008) (0)
- Relationships Between Performance-Based Measures of Physical Fucntion and the Basfi-Questionnaire in Ankylosing Spondylitis Patients (2010) (0)
- OP0261 One-Year Effects of Glucocorticoids on Bone Density. A Meta-Analysis in Cohorts of Patients on High and Low Dose Therapy (2014) (0)
- [Rightsided cardiac congestion with an unusual etiology]. (1980) (0)
- Molecular basis of bortezomib/Velcade ® resistance: Proteasome subunit β 5 (PSMB5) gene mutation and overexpression of PSMB5 protein (2008) (0)
- Renalfindings inrheumatoid arthritis: clinical aspects of132necropsies (1987) (0)
- Inflammatory arthritis and the diagnosis and management of iron deficiency. Authors' reply (2002) (0)
- Determinants of drug resistance in synovial tissue of rheumatoid arthritis patients and implications for therapy (2005) (0)
- Chapter 1 . 3 Thyroid peroxidase antibodies in rheumatoid arthrtitis 1 . 3 B Increased progression of carotid intima media thickness in thyroid peroxidase antibodies positive rheumatoid arthritis patients (2013) (0)
- Commentary Are biologics more effective than classical disease-modifying antirheumatic drugs? (2008) (0)
- Dexamethasone in the primary prevention of rheumatoid arthritis: a randomized trial (2011) (0)
- articleLevels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients : a cohort study (2015) (0)
- [Muscle and joint pain, not a diagnosis but a symptom]. (1985) (0)
- The IgG4 subclass of anti-citrullinated protein antibodies preferentially decreases during treatment with TNF blocking agents in patients with rheumatoid arthritis (2011) (0)
- [Effect of anti-osteoporosis agents on the incidence of vertebral fractures]. (2000) (0)
- [Post-streptococcal diseases, especially in children]. (1995) (0)
- [Candida albicans spondylodiskitis in intravenous heroin abuse]. (1985) (0)
This paper list is powered by the following services:
